Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $2.1 million.

  • Enanta Pharmaceuticals' Interest & Investment Income fell 3494.96% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 3607.31%. This contributed to the annual value of $9.4 million for FY2025, which is 3607.31% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Interest & Investment Income of $2.1 million as of Q3 2025, which was down 3494.96% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Interest & Investment Income peaked at $4.7 million during Q3 2023, and registered a low of $255000.0 during Q1 2022.
  • Over the past 5 years, Enanta Pharmaceuticals' median Interest & Investment Income value was $2.3 million (recorded in 2025), while the average stood at $2.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 88371.5% in 2023, then plummeted by 3982.67% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Interest & Investment Income (Quarter) stood at $258000.0 in 2021, then soared by 284.88% to $993000.0 in 2022, then soared by 332.83% to $4.3 million in 2023, then tumbled by 34.88% to $2.8 million in 2024, then dropped by 26.19% to $2.1 million in 2025.
  • Its Interest & Investment Income stands at $2.1 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.3 million for Q1 2025.